Abstract
Cell analysis is not a new laboratory procedure. Clinical diagnostics using
cells and tissues is one of the oldest disciplines in laboratory medicine.
Histological study of biopsy samples, the complete blood count, and the
enumeration of disease-bearing cells have been used routinely for at least 60
years. In many ways, these disciplines had changed little until the 1990s.
What' s new, however, is the myriad of combinations of tests and technologies
that come together to create a new map of cell diagnostics.
This report covers assay systems that use cells as the basic source material.
Sources of the cells to be studied include peripheral blood, cord blood, bone
marrow, urine, cerebrospinal and other body fluids and tissue samples. The
market is highly diversified involving several lab disciplines, including
- hematology,
- histology,
- cytology,
- microbiology, and
- tissue transplant medicine
It also involves several technologies, including
- complete blood count,
- flow cytometry,
- microscopy, and
- molecular diagnostics
Until recently, there was little interaction between these disciplines and
technologies; hematology analyzers were used for a complete blood count, flow
cytometry for leukocyte analysis, stains for tissue section slides, etc.
Further, most companies involved in one market were rarely active in another.
However, the evolution of molecular tests, cell research, and cell analysis
technologies has turned cell diagnostics into a melting pot of companies,
clinical applications, and technologies.
This completely new edition of Kalorama' s best-selling 2005 report sets out
the coordinates of this new geography and quantifies the market value of
cell-based testing for various applications through 2011. This report
considers the market for, and technology development and commercialization of,
cell-based diagnostic tests for
- cancer management
- hematology
- histopathology/cytology
- microbiology/virology
- blood product safety
- tissue transplant management
- prenatal testing
Cell analysis techniques and trends are discussed from the point of view of
their present and potential market impact. The report discusses cell-based
diagnostic techniques that are currently available and those that are expected
to take their place. The world market for cell and tissue diagnostics is
provided in U.S. dollars for the base year of 2006 with forecasts to 2011.
Market analysis in this report covers world markets; however the reader will
find a bias toward the developed areas of the globe: North America, Japan, and
Western Europe.
The report covers::
- A survey of cell and tissue diagnostics past, present, and future
- The impact of cell-based diagnostics on patient care in selected diseases
- Technological aspects of cell-based diagnostics that impact their use in
routine patient care
- Market trends and issues that can make or break successful
commercialization of cell-based diagnostics
- An analysis of current and future market opportunities for cell-based
analysis
- Discussion of companies and technologies to watch as the cell diagnostics
industry evolves
View Cart
